Clover Health Investments
CLOV
38 hedge funds and large institutions have $447M invested in Clover Health Investments in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
48.24% more ownership
Funds ownership: 0% → 48.24% (+48%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$66.1M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$64.5M |
| 3 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$34.2M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$30.7M |
| 5 |
LCM
LH Capital Markets
New York
|
+$30.1M |
Top Sellers
CLOV Hedge Fund Activity: Q2 2020 in Review
38 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q2 2020, worth a combined $447M.
Buyers outnumbered sellers: 38 funds opened new CLOV positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $66.1M.
- 38 institutional investors held Clover Health Investments (CLOV) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $447M of Clover Health Investments stock for Q2 2020.
- 38 funds opened new Clover Health Investments positions in Q2 2020 and 0 closed out, a net change of +38 holders.
- The largest Clover Health Investments buyer in Q2 2020 was Linden Advisors, an estimated $66.1M added.
Based on aggregated 13F filings for Q2 2020.